Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5022,603.050.21%H 22,717.65 · L 22,546.3upd. 07 Oct, 3:31 PM IST|Sensex72,638.70.35%H 73,018.82 · L 72,468.72upd. 07 Oct, 3:32 PM IST|Bank Nifty55,055.550.62%H 55,340.7 · L 54,636.2upd. 07 Oct, 3:31 PM IST|USD / INR₹96.760.42%H ₹96.85 · L ₹96.33as of 08 Oct, 12:50 AM IST|Gold Intl (10g)₹1,28,421.221.41%H ₹1,30,589.52 · L ₹1,27,276.41as of 08 Oct, 1:25 AM IST|Silver Intl (1kg)₹1,86,405.362.71%H ₹1,92,393.85 · L ₹1,84,258.84as of 08 Oct, 1:25 AM IST|Crude WTI₹8,615.510.45%H ₹8,803.22 · L ₹8,511.98as of 08 Oct, 1:25 AM IST|Bitcoin₹80,70,1042.21%H ₹81,59,440.85 · L ₹79,80,767.15as of 08 Oct, 1:30 AM IST|Ethereum₹2,48,6254.17%H ₹2,53,813.39 · L ₹2,43,436.61as of 08 Oct, 1:30 AM IST|Nifty 5022,603.050.21%H 22,717.65 · L 22,546.3upd. 07 Oct, 3:31 PM IST|Sensex72,638.70.35%H 73,018.82 · L 72,468.72upd. 07 Oct, 3:32 PM IST|Bank Nifty55,055.550.62%H 55,340.7 · L 54,636.2upd. 07 Oct, 3:31 PM IST|USD / INR₹96.760.42%H ₹96.85 · L ₹96.33as of 08 Oct, 12:50 AM IST|Gold Intl (10g)₹1,28,421.221.41%H ₹1,30,589.52 · L ₹1,27,276.41as of 08 Oct, 1:25 AM IST|Silver Intl (1kg)₹1,86,405.362.71%H ₹1,92,393.85 · L ₹1,84,258.84as of 08 Oct, 1:25 AM IST|Crude WTI₹8,615.510.45%H ₹8,803.22 · L ₹8,511.98as of 08 Oct, 1:25 AM IST|Bitcoin₹80,70,1042.21%H ₹81,59,440.85 · L ₹79,80,767.15as of 08 Oct, 1:30 AM IST|Ethereum₹2,48,6254.17%H ₹2,53,813.39 · L ₹2,43,436.61as of 08 Oct, 1:30 AM IST|
0%
real-estate

Medical Device Makers No Longer Need Loan License for Outsourced Sterilization

Arth Vani DeskPublished: 1 min read
Medical Device Makers No Longer Need Loan License for Outsourced Sterilization

Source: ET Real Estate

Recommended for you
Check home-loan rates & eligibility
Explore Home Loans
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

The Indian government has eased regulations for medical device manufacturers, removing the requirement for a loan license when outsourcing sterilization services. This aims to simplify business operations, though new labeling rules are causing concern within the industry.

Key Highlights
  • ▸Medical device makers no longer need a loan license for outsourced sterilization services, simplifying operations.
  • ▸New rules requiring sterilizer license numbers on device labels are concerning manufacturers due to potential export delays and reduced flexibility.
  • ▸The government's aim is to ease business, but the labeling clause might create new logistical challenges for the industry.
  • ▸The EU has been recognized for clinical investigation waivers, potentially easing market entry for some devices.
Key Takeaways
  • ✓Medical device makers no longer need a loan license for outsourced sterilization services, simplifying operations.
  • ✓New rules requiring sterilizer license numbers on device labels are concerning manufacturers due to potential export delays and reduced flexibility.
  • ✓The government's aim is to ease business, but the labeling clause might create new logistical challenges for the industry.
  • ✓The EU has been recognized for clinical investigation waivers, potentially easing market entry for some devices.

The Indian government has announced a significant regulatory change for medical device manufacturers, eliminating the need for a loan license when they outsource sterilization services. This move is expected to streamline business processes for companies involved in the production of medical equipment.

Previously, manufacturers were required to obtain a loan license even when engaging third-party facilities for the crucial sterilization of their medical devices. The removal of this requirement is seen as a step towards reducing bureaucratic hurdles and potentially speeding up the manufacturing cycle.

However, while the industry welcomes the simplification of the loan license process, new labeling rules introduced alongside this change have raised concerns among manufacturers. The new regulations mandate that the sterilizer's license number must be printed directly on the medical device labels. Industry leaders fear this could create significant challenges, particularly for exports.

Manufacturers are worried that this specific labeling requirement might restrict their flexibility in choosing sterilization facilities. They currently prefer the ability to select the fastest available and most efficient sterilization service provider to meet production deadlines and export commitments. Having to print a specific sterilizer's license number on labels could mean that if their primary sterilizer is unavailable or if they need to switch providers, they would incur delays and additional costs for re-labeling or re-packaging.

Such delays could impact the timely delivery of medical devices to international markets, potentially affecting India's competitiveness in the global medical device sector. The industry is advocating for a more flexible approach to labeling that allows for agility in their supply chains.

In a related development, the government has also recognized the European Union for clinical investigation waivers. This means that medical devices approved in the EU may be eligible for waivers from certain clinical investigation requirements in India, further simplifying the market entry process for some devices.

What This Means for the Medical Device Industry

  • Reduced Bureaucracy: Manufacturers no longer need a loan license for outsourced sterilization, simplifying compliance.
  • Potential for Faster Production: The removal of a licensing step could accelerate the manufacturing and delivery of medical devices.
  • Labeling Concerns: New rules requiring sterilizer license numbers on labels may hinder export flexibility and cause shipment delays.
  • Impact on Exports: Manufacturers worry about losing the ability to choose the fastest sterilization facility, potentially affecting global competitiveness.

This article is for informational purposes only and does not constitute professional advice.

Recommended for you
Products related to this story — compare & act
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
14.7%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.3%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
10.9%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
10.4%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
10.3%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
9.3%
3Y CAGR

Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.

Frequently Asked Questions

What is the main change for medical device manufacturers?

Medical device manufacturers no longer need to obtain a loan license when they outsource sterilization services to third-party facilities.

Why are manufacturers concerned about the new labeling rules?

Manufacturers are worried that printing the sterilizer's license number on device labels will reduce their flexibility in choosing sterilization facilities, potentially causing shipment delays and hindering exports if they need to switch providers.

How does this change impact exports of medical devices?

The industry fears that the new labeling requirement could lead to delays in choosing the fastest sterilization facility, thereby impacting the timely delivery of devices to international markets and potentially affecting India's export competitiveness.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

Eli Lilly to Launch Four New Weight-Loss Drugs, Sees Potential in Indian Biotech Despite Funding Lag
Breaking
real-estate

Eli Lilly to Launch Four New Weight-Loss Drugs, Sees Potential in Indian Biotech Despite Funding Lag

Pharmaceutical giant Eli Lilly, driven by the success of Mounjaro and Zepbound, aims to launch up to four new weight-loss products in the coming years. The company acknowledges India's strong biotechnology talent and expertise, but highlights existing challenges in the research funding environment. Eli Lilly has expressed openness to forming partnerships with Indian biotech firms for future collaborations.

7d ago·1 min readListen
ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories
real-estate

ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories

Linux Laboratories has secured approximately ₹584 crore ($70 million) in equity funding from investment giants ChrysCapital and Tata Capital Healthcare Fund III. This significant investment will enable Linux Laboratories to expand its presence in existing and new therapeutic areas within the healthcare sector.

9d ago·1 min readListen
Supreme Court Flags High Cancer Drug Prices, Urges Government Price Cap
Breaking
real-estate

Supreme Court Flags High Cancer Drug Prices, Urges Government Price Cap

The Supreme Court has expressed serious concern over the exorbitant pricing of essential medicines, particularly cancer drugs, sold with huge markups. Justices Vikram Nath and SVN Bhatti urged the government to consider a uniform pricing rule to cap Maximum Retail Prices (MRPs), highlighting the burden on ordinary people and taxpayers.

9d ago·2 min readListen
Niti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice
Breaking
real-estate

Niti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice

Niti Aayog is developing a national quality framework to grade both public and private hospitals in India. This initiative aims to help patients compare healthcare providers more easily and improve overall quality standards. The framework will assess factors like patient safety, clinical outcomes, and readmission rates.

11d ago·2 min readListen